Abstract
Anaesthesiologists have a special interest in pharmacology, maybe even more than other physicians who prescribe drugs and often follow narrow approved dosing guidelines. Anaesthetic drugs can be administered in a wide dose range, with relative under dosage (awareness, muscle tension or pain) adequate dosage and relative over dosage (late recovery, side effects) all being observed within the approved dose range. The art, or the science, of the anaesthetist is to choose both the drug and the dose in order to achieve an adequate level of anaesthesia as fast as possible and maintain it just as long as necessary in any individual patient. Pharmacokinetic and pharmacodynamic modelling helps to achieve these clinical goals by differentiation within the dose-effect relationship into a dose-concentration relationship and a concentration-effect relationship. Clinically, kinetic-dynamic modelling can be used to adjust the dose to a desired level of effect at any time through target-controlled delivery systems.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
E. Gepts, S. L. Shafer, F. Camu, D. R. Stanski, R. Woestenborghs, A. Van Peer, J. J. P. Heykants, Linearity of pharmacokinetics and model estimation of sufentanil, Anesthesiology 83,1194–240 (1995).
S. L. Shafer, D. R. Stanski, Improving the clinical utility of anesthetic drug pharmacokinetics. Anesthesiology 76, 327–30 (1992).
L. B. Sheiner, D. R. Stanski, S. Vozeh, J. Ham, R. D. Miller, Simultaneous modeling of pharmacokinetics and pharmacodynamics: Application to d-tubocurarine, Clinical Pharmacology and Therapeutics 25, 358–71 (1979).
S. L. Shafer, J. R. Varvel, Pharmacokinetics, pharmacodynamics and rational opioid selection. Anesthesiology 74: 53–63 (1991).
M. A. Hughes, P. S. A. Glass, J. R. Jacobs, Context-sensitive half-time in multicompartment pharmacokinetic models for intravenous anesthetic drugs, Anesthesiology 76, 334–41 (1992).
T. W. Schnider, S. L. Shafer, Evolving clinically useful predictors of recovery from intravenous anesthetics, Anesthesiology 83, 902–5 (1995).
P. O. Maitre, S. Vozeh, J. Heykants, J. A. Thomson, D. R. Stanski, Population pharmacokinetics of alfentanil: average dose-plasma concentration relationship and interindividual variability, Anesthesiology 66, 3–12 (1987).
C. F. Minto, T. W. Schnider, T. D. Egan, E. Youngs, H. Lemmens, P. L. Gambus, V. Billard, J. F. Hoke, K. Moore, D. J. Herman, K. T. Muir, J. Mandema, S. L. Shafer, Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development, Anesthesiology 86, 10–23 (1997).
T. W. Schnider, C. F. Minto, P. L. Gambus, C. Andresen, D. B. Goodale, S. L. Shafer, E. J. Youngs, The influence of method of administration and covariates on the pharmacokinetics of propofol in adult volunteers, Anesthesiology 88, 1170–82 (1998).
J. Schuttler, H. Ihmsen, Population pharmacokinetics of propofol: a multicenter study. Anesthesiology 92, 727–38 (2000).
M. E. Ausems, C. C. Hug Jr, D. R. Stanski, A. G. L. Burm, Plasma concentrations of alfentanil required to supplement nitrous oxide anesthesia for general surgery, Anesthesiology 65, 362–73 (1986).
F. Donati, B. Plaud, C. Meistelman, Vecuronium neuromuscular blockade at the adductor muscles of the larynx and adductor pollicis, Anesthesiology 74, 833–7, (1991).
C. F. Minto, T. W. Schnider, S. L. Shafer, Pharmacokinetics and pharmacodynamics of remifentanil. II. Model application, Anesthesiology 86: 240–244, (1997).
T. W. Schnider, C. F. Minto, S. L. Shafer, P. L. Gambus, C. Andresen, D. B. Goodale, E. J. Youngs, The influence of age on propofol pharmacodynamics, Anesthesiology 90, 1502–16 (1990).
T. Kazama, K. Ikeda, K. Morita, M. Kikura, M. Doi, T. Ikeda, T. Kurita, Y. Nakajima, Comparison of the effect-site k(e0)s of propofol for blood pressure and EEG bispectral index in elderly and younger patients, Anesthesiology 90,1517–27 (1999).
C. F. Minto, T. W. Schnider, T. G. Short, K. M. Gregg, A. Gentilini, S. L. Shafer, Response surface model for anesthetic drug interactions, Anesthesiology 92, 1603–16 (2000).
J. Vuyk, F. Engbers, A. G. Burm, A. Vletter, G. E. R. Griever, E. Olofsen, J. G. Bovill, Pharmacodynamic interaction between propofol and alfentanil given for induction of anesthesia, Anesthesiology 84, 288–99 (1996).
T. Katoh, K. Ikeda, The effect od fentanyl on sevoflurane requirements for loss of consciousness and skin incision, Anesthesiology 88,18–24 (1998).
V. Billard, F. Moulla, J. L. Bourgain, A. Megnibeto, D. R. Stanski, Hemodynamic response to induction and intubation. Propofol/fentanyl interaction, Anesthesiology 81 (1994)
J. Vuyk, MJ. Mertens, E. Olofsen, A. G. L. Burm, J. G. Bovill, Propofol Anesthesia and Rational Opioid Selection: Determination of Optimal EC50–EC95 Propofol-Opioid Concentrations that Assure Adequate Anesthesia and a Rapid Return of Consciousness, Anesthesiology 87, 1549–62 (1997).
E. Kruger-Thiemer, Continuous intravenous infusion and multicompartment accumulation, Eur J Pharmacol. 4, 317–24 (1986).
H. Schwilden, A general method for calculating the dosage scheme in linear pharmacokinetics, Eur J Clin Pharmacol 20, 379–86 (1981).
J. Schuttler, H. Schwilden, H. Stoekel, Pharmacokinetics as applied to total intravenous anaesthesia. Practical implications, Anaesthesia 38 Suppl: 53–6 (1983).
M. E. Ausems, D. R. Stanski, C. C. Hug, An Evaluation of the Accuracy of Pharmacokinetic Data for the Computer Assisted Infusion of Alfentanil, Br. J. Anaesth. 57, 1217–25 (1985).
J. M. Alvis, J. G. Reves, A. V. Govier, P. G. Menkhaus, C. E. Henling, J. A. Spain, E. Bradley, Computer-assisted Continuous Infusions of Fentanyl during Cardiac Anesthesia: Comparison with a Manual Method, Anesthesiology 63, 41–9 (1985).
J. R. Jacobs, Analytical solution to the three-compartment pharmacokinetic model, IEEE Trans.Biomed.Eng 35, 763–5 (1988).
S. L. Shafer, L. C. Siegel, J. E. Cooke, J. C. Scott, Testing Computer-controlled Infusion Pumps by Simulation, Anesthesiology 68, 261–6 (1988).
P. O. Maitre, S. L. Shafer, A Simple Pocket Calculator Approach to Predict Anesthetic Drug Concentrations from Pharmacokinetic Data, Anesthesiology 73, 332–6 (1990).
M. White, G. N. C. Kenny, Intravenous propofol anaesthesia using a computerised infusion system, Anaesthesia 45, 204–8 (1990).
J. B. Glenn, The development of ’Diprifusor’: a TCI system for propofol, Anaesthesia 53, Suppl 1: 13–21 (1988).
V. Billard, J. B. Cazalaa, F. Servin, X. Viviand, Anesthésie intraveineuse à objectif de concentration, Ann Fr Anesth Rean 16, 250–73 (1997).
E. Gepts, Pharmacokinetic concepts for TCI anaesthesia, Anaesthesia 53, 4–12 (1998).
M. C. van den Nieuwenhuyzen, F.H. Engbers, J. Vuyk, A.G.L. Burm, Target-controlled infusion systems: role in anaesthesia and analgesia, Clin Pharmacokinet. 38,181–90 (2000).
S. Chaudri, M. White, G. N. Kenny, Induction of anaesthesia with propofol using a target-controlled infusion system, Anaesthesia 47, 553 (1992).
K. R. Watson, SM. Shah, Clinical comparison of ’single agent’ anaesthesia with sevoflurane versus target controlled infusion of propofol, Br J Anaesth 85, 541–6 (2000).
L. Barvais, I. Rausin, J. B. Glen, S. C. Hunter, D. D Hulster, F. Cantraine, A. D Hollander, Administration of propofol by target-controlled infusion in patients undergoing coronary artery surgery, Journal of Cardiothoracic and Vascular Anesthesia 10, 877–83 (1996).
P. Olivier, D. Sirieix, P. Dassier, N. D. Attellis, J. F. Baron, Continuous infusion of remifentanil and target-controlled infusion of propofol for patients undergoing cardiac surgery: a new approach for scheduled early extubation, J. Cardiothorac. Vase.Anesth 14, 29–35 (2000).
C. Newson, G. P. Joshi, R. Victory, P. F. White, Comparison of propofol administration techniques for sedation during monitored anesthesia care, Anesthesia & Analgesia 81,486–91(1995).
D. Russell, M. P. Wilkes, S.C. Hunter, P. Hutton, G. N. Kenny, Manual compared with target-controlled infusion of propofol, Br J.Anaesth. 75, 562–6 (1995).
F. Servin. TCI compared with manually controlled infusion of propofol: a multicentre study, Anaesthesia 53 Suppl 1, 82–6 (1998).
C. Newson, G. P. Joshi, R. Victory, P. F. White, Comparison of propofol administration techniques for sedation during monitored anesthesia care, Anesth.Analg. 81, 486–91 (1995).
S. Suttner, J. Boldt, C. Schmidt, S. Piper, B. Kumle, Cost analysis of target-controlled infusion-based anesthesia compared with standard anesthesia regimens, Anesth.Analg. 88, 77–82 (1999).
M. E. Ausems, J. Vuyk, C. C. Hug Jr, D. R. Stanski, Comparison of a computer-assisted infusion versus intermittent bolus administration of alfentanil as a supplement to nitrous oxide for lower abdominal surgery, Anesthesiology 68, 851–61 (1988).
V. Billard, A. Deleuze, C. Penot, C. Lohberger, F. Kolb, D. Elias, [Sufentanil in balanced anesthesia: need to predict concentrations for dose optimization], Ann Fr Anesth Reanim 18, 237–42 (1999).
J. Somma, A. Donner, K. Zomorodi, R. Sladen, J. Ramsay, E. Geller, S. L. Shafer, Population pharmacodynamics of midazolam administered by target controlled infusion in SICU patients after CABG surgery, Anesthesiology 89, 1430–43 (1998).
S. L. Shafer, Stanpump manual.
J. G. Bovill, Targetting the effect site, On the study and practice of intravenous anaesthesia, Edited by Vuyk J, Engbers F, Groen-Mulder S. Dordrecht, Kluwer Academic Publishers, pp 17–26 (2000).
P. O. Maitre, D. R. Stanski, Bayesian forecasting improves the prediction of intraoperative plasma concentrations of alfentanil, Anesthesiology 69, 652–9 (1988).
Billard, P. Mavoungou, Computer-controlled infusion of neuromuscular blocking agents, On the study and practice of intravenous anaesthesia. Edited by Vuyk J, Engbers F, Groen-Mulder S. Dordrecht, Kluwer Academic Publishers, pp 159–72 (2000).
H. Schwilden, H. Stoeckel, J. Schiittler, Closed-loop feedback control of Propofol anaesthesia by quantitative EEG analysis in humans, BrJAnaesth 62,290–6 (1989).
E. Mortier, M. Struys, T. De Smet, L. Versichelen, G. Roily, Closed-loop controlled administration of propofol using bispectral analysis, Anaesthesia 53,749–54 (1998).
G. N. C. Kenny, H. Mantzaridis, Closed-loop control of propofol anaesthesia, BrJAnaesth 83, 223–8 (1999).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media New York
About this chapter
Cite this chapter
Billard, V. (2003). Clinical Application of Pharmacokinetic and Pharmacodynamic Models. In: Vuyk, J., Schraag, S. (eds) Advances in Modelling and Clinical Application of Intravenous Anaesthesia. Advances in Experimental Medicine and Biology, vol 523. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-9192-8_6
Download citation
DOI: https://doi.org/10.1007/978-1-4419-9192-8_6
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-4830-6
Online ISBN: 978-1-4419-9192-8
eBook Packages: Springer Book Archive